BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15223897)

  • 1. Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection.
    Boleslawski E; Conti F; Sanquer S; Podevin P; Chouzenoux S; Batteux F; Houssin D; Weill B; Calmus Y
    Transplantation; 2004 Jun; 77(12):1815-20. PubMed ID: 15223897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
    Ahmed M; Venkataraman R; Logar AJ; Rao AS; Bartley GP; Robert K; Dodson FS; Shapiro R; Fung JJ; Zeevi A
    Ther Drug Monit; 2001 Aug; 23(4):354-62. PubMed ID: 11477316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
    Mittal SK; Sharma RK; Gupta A; Naik S
    Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation.
    Boleslawski E; BenOthman S; Grabar S; Correia L; Podevin P; Chouzenoux S; Soubrane O; Calmus Y; Conti F
    Clin Transplant; 2008; 22(4):494-501. PubMed ID: 18565100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the use of Calcineurin inhibitors in liver transplantation.
    de Mare-Bredemeijer EL; Metselaar HJ
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production.
    van den Berg AP; Twilhaar WN; Mesander G; van Son WJ; van der Bij W; Klompmaker IJ; Slooff MJ; The TH; de Leij LH
    Transplantation; 1998 Apr; 65(8):1066-71. PubMed ID: 9583867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation.
    Bathgate AJ; Lee P; Hayes PC; Simpson KJ
    Liver Transpl; 2000 Nov; 6(6):721-7. PubMed ID: 11084058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.
    O'Grady JG; Burroughs A; Hardy P; Elbourne D; Truesdale A;
    Lancet; 2002 Oct; 360(9340):1119-25. PubMed ID: 12387959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitors in renal transplantation: what is the best option?
    Tanabe K
    Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
    Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
    Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.
    Yano I
    Drug Metab Pharmacokinet; 2008; 23(3):150-7. PubMed ID: 18574318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.
    Jiang H; Yang XF; Wynn C; Soriano R; Krishnan K; Fujimura T; Kobayashi M
    Transplant Proc; 2001; 33(1-2):510-3. PubMed ID: 11266931
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.